Previous 10 | Next 10 |
Prestige BioPharma Ltd. (KRX: 950210) and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy’s”) today announced that the two companies have entered into a binding agreement for an exclus...
Dr. Reddy's Laboratories (NYSE:RDY) says that the company expects to manufacture PAXLOVID, the investigational COVID-19 pill developed by Pfizer (NYSE:PFE) Dr. Reddy's is also among a handful of Indian drug manufacturers licensed to produce molnupiravir, the rival drug from Merck (NYSE:MRK). ...
Dr. Reddy’s Laboratories (NYSE:RDY) launched Ephedrine Sulfate Injection 50 mg/mL, a generic version of low blood pressure therapy Akovaz, in the U.S. market. Thecompany said Akovaz and generic market had U.S. sales of ~$67.5M MAT for the 12 months ending in August 2021, according to I...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, a therapeutic equivalent generic...
ABBV, ABR, AON, ASIX, B, BAH, BBVA, BLX, OTCQX:BNPQF, CBOE, CCJ, CERN, CHD, CHTR, CL, COWN, CRI, CVX, OTCPK:DDAIF, E, OTCQB:FMCC, OTCQB:FNMA, FTS, GWW, HEXO, HIG, HUN, IMGN, IMO, LAZ, LHX, LYB, MGI, NWG, NWL, OIIM, OXLC, POR, PSX, PSXP, RCL, RDY, RUTH, SHLX, SIFY, SJR, SLCA, OTCPK:SNCAF, OTCQ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsul...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Carmustine for Injection, USP, a therapeutic equivalent generic version of ...
Citius stock price reacted to no safety concerns identified by the DMC, to surge 102.86% (YoY) and +108.82% (YTD). Citius has prioritized E7777 threatening to derail the company's progression with Mino-Lok. Continual medical development may overthrow the use of CVCs due to the hig...
Biopharmaceuticals company Bristol Myers Squibb’s (BMY) strong clinical and operational performance and continued momentum across its product portfolio helped it generate robust revenue growth in its last reported quarter. But given that its stock price has dipped recently, is now an o...
Share price performance has been a massive disappointment since I last covered the stock. I provide my updated valuation of BDSI to represent the acquisition of US and Canadian rights to ELYXYB. My model shows shares are trading at a discount of ~67%. Litigation costs and risks ar...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...